<DOC>
	<DOC>NCT00229970</DOC>
	<brief_summary>This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.</brief_summary>
	<brief_title>MK0476 Study in Adult Patients With Acute Asthma (0476-322)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Adult Patients With Acute Asthma Attacks Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.) Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or Other Severe Disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>